| Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface T Päll, A Pink, L Kasak, M Turkina, W Anderson, A Valkna, P Kogerman PloS one 6 (12), e29305, 2011 | 73 | 2011 |
| Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding T Päll, A Gad, L Kasak, M Drews, S Strömblad, P Kogerman Oncogene 23 (47), 7874-7881, 2004 | 19 | 2004 |
| Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation S Stromblad, T Pall, P Kogerman US Patent 8,192,744, 2012 | 6 | 2012 |
| New drug S Stromblad, P Kogerman, T Pall US Patent App. 10/487,620, 2005 | 6 | 2005 |
| Purification, characterization and plasma half-life of PEGylated soluble recombinant non-HA-binding CD44 A Pink, A Kallastu, M Turkina, M Skolnaja, P Kogerman, T Päll, A Valkna BioDrugs 28, 393-402, 2014 | 1 | 2014 |
| Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation T Pall, W Anderson, L Kasak, A Pink, P Kogerman, A Allikas, A Valkna US Patent 8,524,666, 2013 | 1 | 2013 |
| CD44 Controls Endothelial Proliferation and Functions as Endogenous Inhibitor of Angiogenesis A Pink, M Školnaja, T Päll, A Valkna bioRxiv, 049494, 2016 | | 2016 |
| Studies of CD44 Hyaluronan Binding Domain as Novel Angiogenesis Inhibitor T PÄLL | | 2013 |
| NOVEL INHIBITOR OF ANGIOGENESIS T Päll, W Andderson, L Kasak, A Pink, P Kogerman, A Allikas, A Valkna EP Patent 2,182,975, 2010 | | 2010 |
| NOVEL INHIBITOR OF ANGIOGENESIS T PÄLL, W ANDDERSON, L KASAK, A PINK, P KOGERMAN, A ALLIKAS, ... WO Patent 2,009,010,409, 2009 | | 2009 |
| NEW ANGIOGENESIS INHIBITORS BASED ON SOLUBLE CD44 RECEPTOR HYALURONIC ACID BINDING DOMAIN S Staffan, P Kogerman, T Päll EP Patent 1,418,931, 2008 | | 2008 |
| New drug S Strömblad, P Kogerman, T Päll | | 2003 |
